trial · primary record
Radiotherapy followed by chemotherapy
Lymphoma, Large B-cell, Diffuse
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 432 |
| Primary completion | 2025-07 |
| Primary endpoint | Progression-free survival (PFS) |
| Registry ID | NCT01156259 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:19.557Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01156259
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.